Abstract
Corporate names and trademarks are often treated as operating in parallel domains. Yet, in practice, the same sign frequently performs both functions, collapsing this distinction and exposing structural inconsistencies in the law. This blog examines the tension between trademark priority and corporate name approval, the divergence between confusion and dilution standards, and the misalignment between ex ante screening and ex post enforcement. It argues that while trademark law has evolved to recognise the economic weight of names, company law continues to treat them as neutral identifiers, producing legitimacy gaps and avoidable disputes.
Introduction
In 1966, Mahendra & Mahendra Paper Mills Ltd., a duly incorporated company that had cleared the scrutiny of the corporate registry, proceeded to issue a public prospectus under its registered name. However, Mahindra & Mahindra Ltd. objected to such use and when the dispute reached the courts, the use of that very name was restrained on grounds of passing off and trademark infringement.
The dispute of Mahendra & Mahendra Paper Mills Ltd. v. Mahindra & Mahindra Ltd. (2002) is not an outlier. It reflects a deeper structural tension between two legal regimes that regulate the same linguistic sign but from different premises. Company law treats a name as a matter of registrability and public record whereas trademark law treats it as a repository of goodwill and market identity. The dispute sits precisely at this fault line where administrative approval encounters proprietary claims.
This blog takes that fault line as its starting point and examines how the coexistence of these regimes produces doctrinal misalignment, particularly when corporate names begin to function as trademarks in commerce.
Conceptual Divide: Juridical Name vs Source Sign
Company and trade names identify the legal person and not particular goods or services. They signal to the state and counterparties which entity bears legal obligations. Trademarks, on the other hand, function as source identifiers. They distinguish the commercial origin of goods or services and are a carrier of goodwill, reputation and consumer association, built over decades of use.
The distinction, however, collapses in modern branding, where firms often use the same sign as corporate name, trade name, and house mark. The company name itself then operates as a source identifier.
Trademark law recognises this convergence. The definition of “mark” u/s 2(1)(m) of the Trade Marks Act includes a “name”, and section 29(5) treats use of a registered mark as a company or business name as infringement when used for the same goods or services. However, company law continues to treat names as a question of corporate registrability and public record, and not as access to signs already carrying trademark meaning.
Priority vs Incorporation Legitimacy
Trademark law is anchored in priority of use. Earlier use or registration, coupled with reputation determines the rights. Company law, on the other hand, focuses on prima facie legitimacy through incorporation. Sections 4 and 16 of the Companies Act, 2013 focus on whether a name is “identical” or “too nearly resembles” an existing company or registered trademark, with a time-bound rectification mechanism.
This creates a situation where a later company may be incorporated despite an earlier trademark right, simply because the right-holder has not yet asserted its claims. The burden then shifts to the proprietor to seek rectification or pursue infringement and passing-off claims.
The Delhi High Court’s decision in cGMP Pharmaplan highlights this divergence. A corporate name was ordered to be changed despite an earlier finding of no deceptive similarity in trademark proceedings. Priority in trademark law does not align with the Companies Act’s administrative standards, thereby, producing legitimacy concerns for corporate names that are valid at incorporation but vulnerable when tested against trademark rights.
Confusion vs Dilution Standards
The test for trademark infringement is anchored in likelihood of confusion. In India, this is reflected in sections 2(1)(h) and 29(1)– (3) of the Trade Marks Act, 1999. The judiciary has elaborated the factors of confusion that consider visual, phonetic and conceptual similarity, nature of goods, consumer profile, and surrounding circumstances. Passing off, which is a common law remedy, complements this through the trinity of goodwill, misrepresentation, and damage, allowing courts to capture unfair competition beyond strict infringement.
Well-known marks disrupt this framework by decoupling protection from actual confusion or market overlap. Sections 11(2), 11(6)– (9), and 29(4) recognise dilution of well-known mark and restrain use even for dissimilar goods where it exploits or harms the mark’s distinctiveness or reputation. Cases like Daimler Benz reflect this shift, prioritising protection against free-riding and degradation of famous marks across markets.
Company-name regulation remains closer to a confusion-based test. The standard of “too nearly resembling” focuses on identity or close similarity, typically within the same or related fields. It does not meaningfully engage with dilution. As a result, use of well-known marks in corporate names for unrelated activities, which is vulnerable under section 29(4) of the Trade Marks Act, can still pass name approval because they are treated as corporate identifiers rather than as product brands.
Ex-Ante Screening vs Ex-Post Enforcement
Company law operates ex-ante. Section 4 governs name approval at incorporation or name-change stage, and section 16 permits rectification of objectionable names within a limited period after registration. Trademark law is mostly ex post, with rights enforced through infringement and passing-off actions, oppositions, and rectification after adoption or use.
This misalignment has two effects. A company may adopt and trade under a name that is later found infringing or dilutive, leading to costly rebranding despite initial approval. Second, even when company law revisits the name, it applies its own standards and timelines, while courts apply trademark doctrines, producing inconsistent outcomes, as seen in cGMP Pharmaplan.
Therefore, incorporation offers no safe harbour from trademark liability. At the same time, it does not function as an effective filter against misuse of trademarks in corporate names. The result is persistent uncertainty for both incorporators and trademark owners.
Conclusion
The intersection of trademark law and corporate naming is not merely a question of overlap. It reflects a deeper inconsistency in how the law understands the function of names in commerce. Trademark law recognises that names carry economic meaning, embody reputation, and require protection beyond confusion. Company law, however, continues to treat names as administrative identifiers, assessed through limited and often formalistic standards.
The result is a system that grants legitimacy at incorporation but withdraws it upon judicial scrutiny. Incorporation neither shields against infringement nor meaningfully prevents it. Instead, it shifts the burden onto trademark proprietors to correct what could have been addressed at the threshold.
References
Mahendra And Mahendra Paper Mills Ltd vs Mahindra And Mahindra Ltd 2002 (2) SCC 147
Afroza Begum, “Preserving the distinctiveness of corporate marks: an analysis of legal and judicial approaches to well known trademark in India”, (2018) Journal of Financial Crime, https://doi.org/10.1108/JFC-05-2017-0040
Devesh Aggarwal, “Name Clashes: Resolving Conflicts Between Corporate Identities And Trademarks”
https://www.livelawbiz.com/articles/trademark-vs-company-name-dispute-deceptive-similarity-analysis-312483 (last visited on: 04th May, 2026)
Rohan Joshua Jacob, “A Convergence Of Trade Names And Trade Marks: A Case Comment”, https://www.mondaq.com/india/trademark/1085382/a-convergence-of-trade-names-and-trade-marks-a-case-comment (last visited: 04th May, 2026)
Companies Act, 2013
Trade Marks Act, 1999
cGMP Pharmaplan v. Regional Director 2010 SccOnLine Del 2387
Daimler Benz Aktiegesellschaft vs Hydo Hindustan 1993 SCC OnLine Del 605
Cadilla Healthcare Ltd. vs Cadilla Pharmaceuticals Ltd. 2001 (5) SCC 73
